Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis

Blood20.30
Volume: 117, Issue: 20, Pages: 5541 - 5550
Published: May 19, 2011
Abstract
In this study we investigated the role of CB1 receptor signaling in angiogenesis and the therapeutic exploitation of CB1 inactivation as an antiangiogenic strategy. We started from the observation that CB1 receptor expression is induced during angiogenesis and that the endocannabinoid anandamide stimulated bFGF-induced angiogenesis in the nanomolar physiologic range. To define the functional involvement of CB1 receptor signaling during...
Paper Details
Title
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis
Published Date
May 19, 2011
Journal
Volume
117
Issue
20
Pages
5541 - 5550
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.